How to Make Progress with Electronic Data Capture, Current and Future Status of EDC in Europe
Andy Richardson, Zenetar Ltd; Case Study: Use of EDC at Boehringer Ingelheim, Stephane Collet, Boeringer Ingelheim, Andrew Cooper, Oracle Corp.;
Andy Richardson, Zenetar Ltd; Case Study: Use of EDC at Boehringer Ingelheim, Stephane Collet, Boeringer Ingelheim, Andrew Cooper, Oracle Corp.;
Perceptions of the EDC and Web-based trials in CEE, Peter Heger, Health Research Services, Ltd.
The challenges that exist in Europe are similar to the US, senior management commitment to the use of EDC and appropriate user process and software functionality training. However, in Europe there is a need for a scalable multilingual deployment and support model, there still remains a lack of regulatory direction, and an absence of data interchange standards for investigational site collection - some of those involved in the data collections area may change the standards slightly to meet their needs and thus create a variability in the data collection requirements. Boeringer Ingelheim reported on a successful partnership with both Oracle and HP in using EDC. They reported substantial speed and cost benefits over paper and in house training was reduced through a familiar study design tool-they had used it elsewhere and it was familiar to everyone, so learning the new tool was not difficult. Regarding the CEE survey, investigators and clinical research staff felt that EDC tools are improving the investigators' ability to find and manage patients, but their expectations about tools to find and manage patients are much higher than what the reality of the situation shows.
Articles in this issue
almost 20 years ago
Article
Special Lecture, Networking Dinner, 5 October 2005: Industry Consolidation and the Emerging Shape of R&Dalmost 20 years ago
Article
MEDIDATA SOLUTIONS AND CHINESE STATE FOOD & DRUG ADMINISTRATION HOST E-CLINICAL SEMINAR IN BEIJINGNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025